S&T Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

S&T Bank’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,853	Closed	-$14K	–	103
2023 Q1	$14K	Hold	38,853	–	–	﹤0.01%	100
2022 Q4	$34K	Hold	38,853	–	–	0.01%	109
2022 Q3	$61K	Hold	38,853	–	–	0.01%	109
2022 Q2	$78K	Hold	38,853	–	–	0.01%	123
2022 Q1	$91K	Hold	38,853	–	–	0.01%	130
2021 Q4	$181K	Hold	38,853	–	–	0.03%	136
2021 Q3	$296K	Hold	38,853	–	–	0.05%	119
2021 Q2	$376K	Hold	38,853	–	–	0.06%	109
2021 Q1	$321K	Hold	38,853	–	–	0.05%	114
2020 Q4	$265K	Hold	38,853	–	–	0.05%	117
2020 Q3	$433K	Hold	38,853	–	–	0.1%	87
2020 Q2	$244K	Hold	38,853	–	–	0.06%	101
2020 Q1	$71K	Buy	38,853 +10,683	+38%	+$30.8K	0.02%	97
2019 Q4	$95K	Buy	+28,170	New	+$67.2K	0.02%	94

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

OAJ

Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

S&T Bank's SRNE Position: Q2 2023 in Review

S&T Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 38,853 shares — an estimated $14K sold.

S&T Bank first reported a position in SRNE in Q4 2019 and held it in 14 quarters. The position peaked at $433K in Q3 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

S&T Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
S&T Bank sold 38,853 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $14K.
S&T Bank first reported a position in Sorrento Therapeutics, Inc. in Q4 2019 and held it in 14 quarters.
S&T Bank's Sorrento Therapeutics, Inc. position peaked at $433K in Q3 2020.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on S&T Bank's 13F filing for Q2 2023, filed 14 Aug 2023.